Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects

Neuropsychopharmacology

Volumn 17, Issue 6, 1997, Pages 370-381

  Sundström, Inger ^a   Nyberg, Sigrid ^a   Bäckström, Torbjörn ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Benzodiazepines; GABA(A) receptor; Premenstrual syndrome; Progesterone metabolites; Saccadic eye velocity; Sedation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE DERIVATIVE; ESTRADIOL; MIDAZOLAM; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LUTEAL PHASE; NORMAL HUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; SEDATION;

ADULT; ANTI-ANXIETY AGENTS; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDAZOLAM; MIDDLE AGED; PILOT PROJECTS; PREMENSTRUAL SYNDROME; PROGESTERONE; SACCADES;

EID: 0030711672     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00086-9     Document Type: Article

References (45)

1. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC, U.S. Department of Health and Human Services
2. Ashby CR, Carr LA, Cool CL, Steptoe MM, Franks DD (1988): Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 24:225-233
3. Bäckström T, Sanders D, Leask R, Davidson D, Warner P, Bancroft J (1983): Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 45:503-507
4. Ball DM, Glue P, Wilson S, Nutt DJ (1991): Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology 105:361-367
5. Baloh RW, Sills AW, Kumley WE, Honrubia V (1975): Quantitative measurement of saccade amplitude, duration, and velocity. Neurology 25:1065-1070
6. Bancroft J, Cook A, Davidson D, Bennie J, Goodwin G (1991): Blunting of neuroendocrine responses to infusion of L-tryptophan in women with perimenstrual mood change. Psychol Med 21:305-312
7. Becker W (1989): Metrics. In Wurtz RH, Goldberg ME (eds), The Neurobiology of Saccadic Eye Movements. Amsterdam, Elsevier Science Publishers BV, pp 13-67
8. A receptor function. Pharmacol Biochem Behav 45:423-428
9. Buhrer M, Maitre PO, Crevoisier C, Stanski DR (1990): Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin Pharmacol Ther 48:555-567
10. Cowley DS, Roy-Burne PP, Greenblatt DJ, Hommer DW (1993): Personality and benzodiazepine sensitivity in anxious patients and control subjects. Psychiatry Res 47:151-162
11. Freeman EW, Rickels K, Sondheimer SJ, Polansky M (1995): A double-blind trial of oral progesterone, alprazolam and placebo in treatment of severe premenstrual syndrome. JAMA 274:51-57
12. Glue P, Bailey J, Wilson S, Hudson A, Nutt DJ (1992): Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci 50:25-30
13. Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI (1989): Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 45:356-365
14. Halbreich U, Petty F, Yonkers K, Kramer GL, Rush AJ, Bibi KW (1996): Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry 153:718-720
15. Hammarbäck S, Ekholm UB, Bäckström T (1991): Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol (Copenh) 125:132-137
16. Hammabäck S, Bäckström T (1988): Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gynecol Scand 67:159-166
17. Hammarbäck S, Bäckström T, MacGibbon-Taylor B (1989a): Diagnosis of premenstrual tension syndrome: Description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Obstet Gynaecol 10:25-42
18. Hammarbäck S, Damber J-E, Bäckström T (1989b): Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 68:125-130
19. Hikosaka O, Wurtz RH (1985a): Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in the monkey superior colliculus. J Neurophysiol 53:266-291
20. Hikosaka O, Wurtz RH (1985b): Modification of saccadic eye movements by GABA-related substances. II. Effects of muscimol and bicuculline in the monkey substantia nigra pars reticulata. J Neurophysiol 53:292-308
21. Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingarter H, Paul SM (1986): Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 43:542-551
22. Hopfenbeck JR, Cowley DS, Radant A, Greenblatt DJ, Roy-Burne PP (1995): Effects of diphenhydramine on human eye movements. Psychopharmacology 118:280-286
23. Ingum J, Pettersen G, Sager G, Morland J (1994): Relationship between unbound plasma concentrations and various psychomotor and subjective effects after intake of diazepam and flunitrazepam. Int Clin Psychopharmacol 9:115-121
24. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM (1986): Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232: 1004-1007
25. Marshall RW, Griffiths AN, Richens A (1985): A microcomputer system to assess CNS depression from the analysis of the dynamics of saccadic eye movements. Br J Clin Pharmacol 20:304-305
26. Marshall RW, Richens A (1989): An IBM-based system for the generation, collection and analysis of saccadic and smooth pursuit eye movements. Br J Clin Pharmacol 28:752-753
27. McAuley JW, Reynolds IJ, Kroboth FJ, Smith RB, Kroboth PD (1995): Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women. J Clin Psychopharmacol 15:3-11
28. McCormack HM, Horne DJdL, Sheather S (1988): Clinical application of visual analogue scales: A critical review. Psychol Med 18:1007-1019
29. Mercer AJ, Marshall RW, Richens A (1990): Saccadic eye movements as a method of psychometric assessment. In Klepper ID, Saunder LD, Rosen M (eds), Ambulatory Anaesthesia and Sedation. Oxford, Blackwell, pp 88-105
30. Linnoila M, Erwin CW, Brendle A, Simpson D (1983): Psychomotor effects of diazepam in anxious patients and healthy volunteers. J Clin Psychopharmacol 3:88-96
31. Okada Y (1992): The distribution and function of γ-aminobutyric acid (GABA) in the superior colliculus. In Mize RR, Marc RE, Silito AM (eds), Progress in Brain Research. Amsterdam, Elsevier Science Publishers BV, pp 249-262
32. Parry BL, Gerner RH, Wilkins JN, Halaris AE, Carlson HE, Hershman JM, Linnoila M, Merrill J, Gold PW, Gracely R (1991): CSF and endocrine studies of premenstrual syndrome. Neuropsychopharmacology 5:127-137
33. Paul SM, Purdy RH (1992): Neuroactive steroids. FASEB J 6:2311-2322
34. Purdy RH, Morrow AL, Moore PH, Paul SM (1991): Stress-induced elevations of the γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci USA 88:4553-4557
35. Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ (1985): Midazolam: Pharmacology and uses. Anesthesiology 62:310-324
36. Rojansky N, Halbreich U, Zander K, Barkai A, Goldstein S (1991): Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest 31:146-152
37. Roy-Burne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer D (1990): Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 47:534-538
38. Schmidt PJ, Purdy RH, Moore PH, Paul SM, Rubinow DR (1994): Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79:1256-1260
39. Smith S, Rinehart JS, Ruddock VE, Schiff I (1987): Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized cross-over clinical trial. Obstet Gynecol 70:37-43
40. Sundblad C, Modigh K, Andersch B, Eriksson E (1992): Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial. Acta Psychiatr Scand 85:39-47
41. Sundström I, Ashbrook D, Bäckström T (1997): Reduced benzodiazepine sensitivity in patients with premenstrual syndrome, a pilot study. Psychoneuroendocrinology 22:25-38
42. Wang MD, Seippel L, Purdy RH, Bäckström T (1996): Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5α-pregnan-3,20-dione and 3α-hydroxy-5α-pregnan-20-one. J Clin Endocrinol Metab 81:1076-1082
43. Veeninga AT, Westenberg HGM (1992): Serotonergic function and late luteal phase dysphoric disorder. Psychopharmacology 108:153-158
44. Wieland S, Lan NC, Mirasedeghi S, Gee KW (1991): Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565:263-268
45. Wong PT, Yoong YL, Gwee MC (1986): Acute tolerance to diazepam induced by benzodiazepines. Clin Exp Pharmacol Physiol 13:1-8